Schedule 13G ownership disclosure

PMV PHARMACEUTICALS INC

Common stock, par $0.00001 per share (the "Shares") · CUSIP: 69353Y103

Event date: 2025-02-13

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • PFM Health Sciences, LP

    Shares: 2,598,827.00 · Class: 5.0%

  • PFM Health Sciences GP, LLC

    Shares: 2,598,827.00 · Class: 5.0%

  • Partner Asset Management, LLC

    Shares: 2,598,827.00 · Class: 5.0%

  • Brian D. Grossman

    Shares: 2,598,827.00 · Class: 5.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-016122
Form type
SCHEDULE 13G
Filer
PFM Health Sciences, LP
CIK
CIK 1442756
Filed
Feb 21, 2025
Reporting period
Feb 13, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub